Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
Figure 2
Effect of micronized PEA on each single neuropathic pain symptom assessed by Total Symptom Score (TSS). The intensity and frequency of pain, burning, paresthesia, and numbness, evaluated by TSS, show a significant mitigation () after 60 days of treatment compared to baseline. This effect persists even one month after treatment discontinuation.
